Structurally diverse zinc(<scp>ii</scp>) complexes containing tripodal tetradentate phenoxido-amines with promising antiproliferative effects-Reference-Cited by-同舟云学术

Structurally diverse zinc(ii) complexes containing tripodal tetradentate phenoxido-amines with promising antiproliferative effects

Published:2024 Issue:29 Volume:53 Page:12261-12280
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Massoud Salah S.¹²^ORCID,Mautner Franz A.³,Louka Febee R.¹,Salem Nahed M. H.²,Fischer Roland C.⁴^ORCID,Torvisco Ana⁴,Vančo Ján⁵^ORCID,Belza Jan⁵^ORCID,Dvořák Zdeněk⁶,Trávníček Zdeněk⁵^ORCID

Affiliation:

1. Department of Chemistry, University of Louisiana at Lafayette, P.O. Box 43700, Lafayette, LA 70504, USA

2. Department of Chemistry, Faculty of Science, Alexandria University, Moharam Bey 21511, Alexandria, Egypt

3. Institut für Physikalische and Theoretische Chemie, Technische Universität Graz, Stremayrgasse 9/II, A-8010, Graz, Austria

4. Institut für Anorganische Chemische, Technische Universität Graz, Stremayrgasse 9/V, A-8010 Graz, Austria

5. Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University, Šlechtitelů 27, CZ-779 00 Olomouc, Czech Republic

6. Department of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-783 71 Olomouc, Czech Republic

Abstract

Structurally diverse zinc(ii) complexes with tripodal tetradentate phenolic-amines of variable substituents in the phenol and amine moieties were synthesized and thoroughly characterized.

Funder

University of Louisiana at Lafayette

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/DT/D4DT00942H

Reference111 articles.

1. Cisplatin: The first metal based anticancer drug

2. R.Oun and N. J.Wheate , Encyclopedia of Metalloproteins: Platinum Anticancer Drugs , 2013 , pp. 1710–1714 . 10.1007/978-1-4614-1533-6_525

3. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs